Home › Companies › FATE THERAPEUTICS INC. › 2023-2024
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and FATE THERAPEUTICS INC.’s Form 8-K, filed June 7, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 7, 2024: 7 items on FATE THERAPEUTICS INC.’s Form 8-K, filed June 7, 2024: 3 elected · 4 passed (calculated).
Notable dissent: 1 say-on-pay vote (71.9% support); 2 other board items (36.8%, 34.4% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore FATE THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are FATE THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 7, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: William H. Rastetter, Ph.D. | 82,587,977 | -- | -- | 8,440,527 | 7,162,328 | 91% | Elected | — |
| Elect Director: Michael Lee | 90,262,212 | -- | -- | 1,188,429 | 6,740,191 | 99% | Elected | — |
| Elect Director: Yuan Xi, Ph.D. | 89,732,567 | -- | -- | 1,718,074 | 6,740,191 | 98% | Elected | — |
| (ii) Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. | 96,478,449 | 113,003 | 1,599,380 | -- | -- | 99.9% | Passed (calculated) | — |
| (iii) Non-binding Advisory Vote on Compensation of Named Executive Officers. | 65,401,635 | 25,615,148 | 433,964 | -- | 6,740,085 | 72% | Passed (calculated) | — |
| (v) Approval of the 2022 A&R Plan to increase the number of shares of common stock reserved for issuance thereunder. | 59,762,463 | 31,270,315 | 417,969 | -- | 6,740,085 | 66% | Passed (calculated) | — |
| (vi) Approval of the adjournment of the Annual Meeting to the extent there are insufficient votes at the Annual Meeting to approve any of the above proposals. | 57,506,789 | 33,547,222 | 396,736 | -- | 6,740,085 | 63% | Passed (calculated) | — |
This meeting is also recorded here as June 3, 2024; both records come from the same filing, so the date should be checked against it.
Source: FATE THERAPEUTICS INC., Form 8-K, filed with the SEC on June 7, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2023-2024: shareholder support by sector and by company size.
198 asset managers disclosed a vote on at least one FATE THERAPEUTICS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of FATE THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 3 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: Election of Class II Directors: Michael Lee
FATE THERAPEUTICS INC.’s own tally for this item (“Elect Director: Michael Lee”): 90,262,212 for, 1,188,429 withheld, per its Form 8-K filed June 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “All matters submitted to a vote of the Company's stockholders at the Annual Meeting were approved and all director nominees were elected.”
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 64 asset managers below reported 26,563,963 for, 385,404 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,406,861 | 0 | 0 | 0 | For |
| State Street | 5,966,054 | 0 | 0 | 14,397 | For |
| Fidelity | 1,717,438 | 0 | 0 | 235,209 | Mixed |
| BlackRock | 1,739,687 | 0 | 0 | 0 | For |
| Federated Hermes | 969,514 | 0 | 0 | 0 | For |
| Charles Schwab | 960,886 | 0 | 0 | 0 | For |
| Invesco | 800,607 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 617,951 | 0 | 0 | 0 | For |
| JPMorgan | 559,857 | 0 | 0 | 0 | For |
| Victory Capital | 338,122 | 0 | 0 | 0 | For |
| TIAA | 293,883 | 0 | 0 | 0 | For |
| Dimensional | 278,508 | 0 | 0 | 0 | For |
| Nationwide | 237,424 | 0 | 0 | 0 | For |
| Equitable | 136,890 | 0 | 0 | 100,380 | Mixed |
| Columbia Threadneedle | 236,948 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 220,744 | 0 | 0 | 0 | For |
| Goldman Sachs | 195,010 | 0 | 0 | 0 | For |
| Brighthouse | 175,922 | 0 | 0 | 0 | For |
| MFS | 161,313 | 0 | 0 | 0 | For |
| T. Rowe Price | 157,978 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 157,973 | 0 | 0 | 0 | For |
| BRUCE FUND INC | 143,000 | 0 | 0 | 0 | For |
| American Century | 135,406 | 0 | 0 | 0 | For |
| ProShares | 120,872 | 0 | 0 | 0 | For |
| Putnam | 118,215 | 0 | 0 | 0 | For |
Showing the 25 largest of 64 asset managers. All 64 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
Description as filed by funds: Election of Class II Directors: William H. Rastetter, Ph.D.
FATE THERAPEUTICS INC.’s own tally for this item (“Elect Director: William H. Rastetter, Ph.D.”): 82,587,977 for, 8,440,527 withheld, per its Form 8-K filed June 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “All matters submitted to a vote of the Company's stockholders at the Annual Meeting were approved and all director nominees were elected.”
Support: 91% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 64 asset managers below reported 20,381,803 for, 6,567,564 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,406,861 | 0 | 0 | 0 | For |
| State Street | 127,836 | 0 | 0 | 5,852,615 | Withhold |
| Fidelity | 1,717,438 | 0 | 0 | 235,209 | Mixed |
| BlackRock | 1,739,687 | 0 | 0 | 0 | For |
| Federated Hermes | 969,514 | 0 | 0 | 0 | For |
| Charles Schwab | 960,886 | 0 | 0 | 0 | For |
| Invesco | 800,607 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 617,951 | 0 | 0 | 0 | For |
| JPMorgan | 559,857 | 0 | 0 | 0 | For |
| Victory Capital | 338,122 | 0 | 0 | 0 | For |
| TIAA | 293,883 | 0 | 0 | 0 | For |
| Dimensional | 278,508 | 0 | 0 | 0 | For |
| Nationwide | 237,424 | 0 | 0 | 0 | For |
| Equitable | 136,890 | 0 | 0 | 100,380 | Mixed |
| Columbia Threadneedle | 0 | 0 | 0 | 236,948 | Withhold |
| AIG/SunAmerica | 220,744 | 0 | 0 | 0 | For |
| Goldman Sachs | 195,010 | 0 | 0 | 0 | For |
| Brighthouse | 175,922 | 0 | 0 | 0 | For |
| MFS | 161,313 | 0 | 0 | 0 | For |
| T. Rowe Price | 157,978 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 157,973 | 0 | 0 | 0 | For |
| BRUCE FUND INC | 143,000 | 0 | 0 | 0 | For |
| American Century | 135,406 | 0 | 0 | 0 | For |
| ProShares | 120,872 | 0 | 0 | 0 | For |
| Putnam | 118,215 | 0 | 0 | 0 | For |
Showing the 25 largest of 64 asset managers. All 64 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
97% of fund votes cast · no official result
The 63 asset managers below reported 26,259,453 for, 689,610 withheld. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,406,861 | 0 | 0 | 0 | For |
| State Street | 5,966,054 | 0 | 0 | 14,397 | For |
| Fidelity | 1,717,438 | 0 | 0 | 235,209 | Mixed |
| BlackRock | 1,739,687 | 0 | 0 | 0 | For |
| Federated Hermes | 969,514 | 0 | 0 | 0 | For |
| Charles Schwab | 960,886 | 0 | 0 | 0 | For |
| Invesco | 800,607 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 617,951 | 0 | 0 | 0 | For |
| JPMorgan | 559,857 | 0 | 0 | 0 | For |
| Victory Capital | 338,122 | 0 | 0 | 0 | For |
| TIAA | 293,883 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 278,508 | Withhold |
| Nationwide | 237,424 | 0 | 0 | 0 | For |
| Equitable | 136,890 | 0 | 0 | 100,380 | Mixed |
| Columbia Threadneedle | 236,948 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 220,744 | 0 | 0 | 0 | For |
| Goldman Sachs | 195,010 | 0 | 0 | 0 | For |
| Brighthouse | 175,922 | 0 | 0 | 0 | For |
| MFS | 161,313 | 0 | 0 | 0 | For |
| T. Rowe Price | 157,978 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 157,973 | 0 | 0 | 0 | For |
| BRUCE FUND INC | 143,000 | 0 | 0 | 0 | For |
| American Century | 135,406 | 0 | 0 | 0 | For |
| ProShares | 120,872 | 0 | 0 | 0 | For |
| Putnam | 118,215 | 0 | 0 | 0 | For |
Showing the 25 largest of 63 asset managers. All 63 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
97% of fund votes cast · no official result
Description as filed by funds: To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to include an officer exculpation provision that limits the liability of certain of its officers as permitted under current Delaware law.
The 64 asset managers below reported 26,036,836 for, 877,113 against, 35,418 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,406,861 | 0 | 0 | 0 | For |
| State Street | 5,970,117 | 10,334 | 0 | 0 | For |
| Fidelity | 1,952,647 | 0 | 0 | 0 | For |
| BlackRock | 1,739,687 | 0 | 0 | 0 | For |
| Federated Hermes | 969,514 | 0 | 0 | 0 | For |
| Charles Schwab | 960,886 | 0 | 0 | 0 | For |
| Invesco | 800,607 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 617,951 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 559,857 | 0 | 0 | Against |
| Victory Capital | 338,122 | 0 | 0 | 0 | For |
| TIAA | 293,883 | 0 | 0 | 0 | For |
| Dimensional | 278,508 | 0 | 0 | 0 | For |
| Nationwide | 236,109 | 1,315 | 0 | 0 | For |
| Equitable | 237,270 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 236,948 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 220,744 | 0 | 0 | 0 | For |
| Goldman Sachs | 195,010 | 0 | 0 | 0 | For |
| Brighthouse | 18,491 | 157,431 | 0 | 0 | Mixed |
| MFS | 161,313 | 0 | 0 | 0 | For |
| T. Rowe Price | 157,978 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 157,973 | 0 | 0 | 0 | For |
| BRUCE FUND INC | 143,000 | 0 | 0 | 0 | For |
| American Century | 135,406 | 0 | 0 | 0 | For |
| ProShares | 120,872 | 0 | 0 | 0 | For |
| Putnam | 118,215 | 0 | 0 | 0 | For |
Showing the 25 largest of 64 asset managers. All 64 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
63% Majority: yes · of votes cast
Description as filed by funds: To approve the adjournment of the Annual Meeting to the extent there are insufficient votes at the Annual Meeting to approve any of the above proposals.
FATE THERAPEUTICS INC.’s own tally for this item (“(vi) Approval of the adjournment of the Annual Meeting to the extent there are insufficient votes at the Annual Meeting to approve any of the above proposals.”): 57,506,789 for, 33,547,222 against, per its Form 8-K filed June 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 63% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 64 asset managers below reported 16,392,183 for, 10,521,766 against, 35,418 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,355,861 | 51,000 | 0 | 0 | For |
| State Street | 65,053 | 5,915,398 | 0 | 0 | Against |
| Fidelity | 1,693,538 | 259,109 | 0 | 0 | Mixed |
| BlackRock | 1,739,687 | 0 | 0 | 0 | For |
| Federated Hermes | 969,514 | 0 | 0 | 0 | For |
| Charles Schwab | 960,886 | 0 | 0 | 0 | For |
| Invesco | 0 | 800,607 | 0 | 0 | Against |
| Direxion Shares ETF Trust | 0 | 617,951 | 0 | 0 | Against |
| JPMorgan | 559,857 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 338,122 | 0 | 0 | Against |
| TIAA | 0 | 293,883 | 0 | 0 | Against |
| Dimensional | 0 | 278,508 | 0 | 0 | Against |
| Nationwide | 0 | 237,424 | 0 | 0 | Against |
| Equitable | 232,470 | 4,800 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 236,948 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 220,744 | 0 | 0 | Against |
| Goldman Sachs | 0 | 195,010 | 0 | 0 | Against |
| Brighthouse | 157,431 | 18,491 | 0 | 0 | Mixed |
| MFS | 0 | 161,313 | 0 | 0 | Against |
| T. Rowe Price | 0 | 157,978 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 157,973 | 0 | 0 | 0 | For |
| BRUCE FUND INC | 143,000 | 0 | 0 | 0 | For |
| American Century | 0 | 135,406 | 0 | 0 | Against |
| ProShares | 0 | 120,872 | 0 | 0 | Against |
| Putnam | 118,215 | 0 | 0 | 0 | For |
Showing the 25 largest of 64 asset managers. All 64 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
66% Majority: yes · of votes cast
Description as filed by funds: To approve the amendment and restatement of the Company's 2022 Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder.
FATE THERAPEUTICS INC.’s own tally for this item (“(v) Approval of the 2022 A&R Plan to increase the number of shares of common stock reserved for issuance thereunder.”): 59,762,463 for, 31,270,315 against, per its Form 8-K filed June 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a majority of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 66% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 65 asset managers below reported 16,763,054 for, 10,107,654 against, 78,817 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,355,861 | 51,000 | 0 | 0 | For |
| State Street | 65,053 | 5,915,398 | 0 | 0 | Against |
| Fidelity | 1,693,538 | 259,109 | 0 | 0 | Mixed |
| BlackRock | 1,739,687 | 0 | 0 | 0 | For |
| Federated Hermes | 969,514 | 0 | 0 | 0 | For |
| Charles Schwab | 960,886 | 0 | 0 | 0 | For |
| Invesco | 800,607 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 617,951 | 0 | 0 | Against |
| JPMorgan | 0 | 559,857 | 0 | 0 | Against |
| Victory Capital | 0 | 338,122 | 0 | 0 | Against |
| TIAA | 293,883 | 0 | 0 | 0 | For |
| Dimensional | 0 | 278,508 | 0 | 0 | Against |
| Nationwide | 1,315 | 236,109 | 0 | 0 | Against |
| Equitable | 232,470 | 4,800 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 236,948 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 220,744 | 0 | 0 | Against |
| Goldman Sachs | 0 | 195,010 | 0 | 0 | Against |
| Brighthouse | 0 | 175,922 | 0 | 0 | Against |
| MFS | 0 | 161,313 | 0 | 0 | Against |
| T. Rowe Price | 0 | 157,978 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 157,973 | 0 | 0 | 0 | For |
| BRUCE FUND INC | 143,000 | 0 | 0 | 0 | For |
| American Century | 0 | 135,406 | 0 | 0 | Against |
| ProShares | 0 | 120,872 | 0 | 0 | Against |
| Putnam | 0 | 118,215 | 0 | 0 | Against |
Showing the 25 largest of 65 asset managers. All 65 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
72% Majority: yes · of votes cast
Prior year: 96.2% for (June 6, 2023 meeting) ▼ 24.3 pts
Description as filed by funds: To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement.
FATE THERAPEUTICS INC.’s own tally for this item (“(iii) Non-binding Advisory Vote on Compensation of Named Executive Officers.”): 65,401,635 for, 25,615,148 against, per its Form 8-K filed June 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 72% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of FATE THERAPEUTICS INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Advisory Vote to Ratify Named Executive Officers' Compensation” (5 managers, 13,341 for, 3,451,652 against).
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,355,861 | 51,000 | 0 | 0 | For |
| State Street | 5,892,937 | 87,514 | 0 | 0 | For |
| Fidelity | 1,693,538 | 259,109 | 0 | 0 | Mixed |
| BlackRock | 1,739,687 | 0 | 0 | 0 | For |
| Federated Hermes | 969,514 | 0 | 0 | 0 | For |
| Charles Schwab | 960,886 | 0 | 0 | 0 | For |
| Invesco | 0 | 800,607 | 0 | 0 | Against |
| Direxion Shares ETF Trust | 0 | 617,951 | 0 | 0 | Against |
| JPMorgan | 0 | 559,857 | 0 | 0 | Against |
| Victory Capital | 0 | 338,122 | 0 | 0 | Against |
| TIAA | 0 | 293,883 | 0 | 0 | Against |
| Dimensional | 0 | 278,508 | 0 | 0 | Against |
| Nationwide | 1,315 | 236,109 | 0 | 0 | Against |
| Equitable | 132,090 | 105,180 | 0 | 0 | Mixed |
| Columbia Threadneedle | 236,948 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 220,744 | 0 | 0 | Against |
| Goldman Sachs | 0 | 195,010 | 0 | 0 | Against |
| Brighthouse | 0 | 175,922 | 0 | 0 | Against |
| MFS | 0 | 161,313 | 0 | 0 | Against |
| T. Rowe Price | 0 | 157,978 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 157,973 | 0 | 0 | 0 | For |
| BRUCE FUND INC | 143,000 | 0 | 0 | 0 | For |
| American Century | 0 | 135,406 | 0 | 0 | Against |
| ProShares | 0 | 120,872 | 0 | 0 | Against |
| Putnam | 118,215 | 0 | 0 | 0 | For |
Fund voting reports, all 64 managers: 21,860,580 for, 5,009,970 against, 78,817 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Redmile Group, LLC | 13,169,057 | 0 | 0 | 0 | For |
| State Street | 7,012,735 | 97,718 | 0 | 0 | For |
| Deep Track Capital, LP | 5,331,578 | 0 | 0 | 0 | For |
| Bellevue Group AG | 0 | 4,839,779 | 0 | 0 | Against |
| BlackRock | 3,701,355 | 31,116 | 0 | 0 | For |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | 0 | 0 | 0 | For |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,098,500 | 0 | 0 | 0 | For |
| DE Shaw | 0 | 2,261,602 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 1,805,306 | 0 | 0 | 0 | For |
| Woodline Partners LP | 1,726,686 | 0 | 0 | 0 | For |
| Citadel | 1,687,757 | 0 | 0 | 0 | For |
| ORBIMED ADVISORS LLC | 1,301,162 | 0 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0 | 1,201,667 | 0 | 0 | Against |
| Two Sigma | 0 | 1,186,681 | 0 | 0 | Against |
| Point72 | 0 | 1,107,330 | 0 | 0 | Against |
| Holocene Advisors, LP | 0 | 1,075,781 | 0 | 0 | Against |
| Federated Hermes | 975,473 | 0 | 0 | 0 | For |
| Charles Schwab | 960,886 | 0 | 0 | 0 | For |
| Invesco | 0 | 827,152 | 0 | 0 | Against |
| Vestal Point Capital, LP | 0 | 800,000 | 0 | 0 | Against |
| ACADIAN ASSET MANAGEMENT LLC | 0 | 665,307 | 0 | 0 | Against |
| Rafferty Asset Management, LLC | 0 | 617,951 | 0 | 0 | Against |
| JPMorgan | 0 | 450,848 | 0 | 0 | Against |
| Northern Trust | 413,582 | 4,764 | 0 | 0 | For |
| Vanguard | 390,450 | 0 | 0 | 0 | For |
Institutional-manager reports, all 154 managers: 46,606,245 for, 18,541,610 against, 316,220 abstained, 3,000 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Prior year: 99.8% for (June 6, 2023 meeting) ▲ 0.1 pts
Description as filed by funds: To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024.
FATE THERAPEUTICS INC.’s own tally for this item (“(ii) Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.”): 96,478,449 for, 113,003 against, per its Form 8-K filed June 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 64 asset managers below reported 26,903,311 for, 10,638 against, 35,418 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,406,861 | 0 | 0 | 0 | For |
| State Street | 5,970,117 | 10,334 | 0 | 0 | For |
| Fidelity | 1,952,647 | 0 | 0 | 0 | For |
| BlackRock | 1,739,687 | 0 | 0 | 0 | For |
| Federated Hermes | 969,514 | 0 | 0 | 0 | For |
| Charles Schwab | 960,886 | 0 | 0 | 0 | For |
| Invesco | 800,607 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 617,951 | 0 | 0 | 0 | For |
| JPMorgan | 559,857 | 0 | 0 | 0 | For |
| Victory Capital | 338,122 | 0 | 0 | 0 | For |
| TIAA | 293,883 | 0 | 0 | 0 | For |
| Dimensional | 278,508 | 0 | 0 | 0 | For |
| Nationwide | 237,424 | 0 | 0 | 0 | For |
| Equitable | 237,270 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 236,948 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 220,744 | 0 | 0 | 0 | For |
| Goldman Sachs | 195,010 | 0 | 0 | 0 | For |
| Brighthouse | 175,922 | 0 | 0 | 0 | For |
| MFS | 161,313 | 0 | 0 | 0 | For |
| T. Rowe Price | 157,978 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 157,973 | 0 | 0 | 0 | For |
| BRUCE FUND INC | 143,000 | 0 | 0 | 0 | For |
| American Century | 135,406 | 0 | 0 | 0 | For |
| ProShares | 120,872 | 0 | 0 | 0 | For |
| Putnam | 118,215 | 0 | 0 | 0 | For |
Showing the 25 largest of 64 asset managers. All 64 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 113,798,942 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 8.27% |
| 2 | State Street | 5.26% |
| 3 | Fidelity | 1.72% |
| 4 | BlackRock | 1.53% |
| 5 | Federated Hermes | 0.85% |
| 6 | Charles Schwab | 0.84% |
| 7 | Invesco | 0.70% |
| 8 | Direxion Shares ETF Trust | 0.54% |
| 9 | JPMorgan | 0.49% |
| 10 | Victory Capital | 0.30% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Redmile Group, LLC | 11.57% |
| 2 | State Street | 6.25% |
| 3 | Deep Track Capital, LP | 4.69% |
| 4 | Bellevue Group AG | 4.25% |
| 5 | BlackRock | 3.28% |
| 6 | Johnson & Johnson Innovation - JJDC, Inc. | 2.97% |
| 7 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2.72% |
| 8 | DE Shaw | 1.99% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 1.59% |
| 10 | Woodline Partners LP | 1.52% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Entities affiliated with Redmile Group, LLC | 13,169,057 | 11.57% | Proxy statement (DEF 14A), proxy filed April 26, 2024 |
| BlackRock | 10,680,727 | 9.39% | Form 13F, quarter ended March 31, 2024 |
| ARK Investment Management LLC | 10,312,167 | 9.06% | Proxy statement (DEF 14A), proxy filed April 26, 2024 |
| Vanguard Group | 8,798,491 | 7.73% | Form 13F, quarter ended March 31, 2024 |
| State Street | 8,036,669 | 7.06% | Form 13F, quarter ended March 31, 2024 |
| Boxer Capital, LLC | 6,171,000 | 5.42% | Proxy statement (DEF 14A), proxy filed April 26, 2024 |
| Citadel Advisors | 3,154,626 | 2.77% | Form 13F, quarter ended March 31, 2024 |
| D.E. Shaw | 2,730,966 | 2.40% | Form 13F, quarter ended March 31, 2024 |
| Geode Capital | 1,905,983 | 1.67% | Form 13F, quarter ended March 31, 2024 |
| Point72 | 1,584,300 | 1.39% | Form 13F, quarter ended March 31, 2024 |
Percentages above are of 113,798,942 shares outstanding, as reported by FATE THERAPEUTICS INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At FATE THERAPEUTICS INC.'s shareholder meeting held June 7, 2024, in the 2023-2024 proxy season, 198 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 1,771 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of the Company's named executive officers as… — FOR was 72% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: FATE THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 7, 2024.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from FATE THERAPEUTICS INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
FATE THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Proxy Votes Now, “FATE THERAPEUTICS (FATE) 2024 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/fate-therapeutics-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.